IMMUNOMIC THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 03 Apr 2023)
What this means for you
This application is over — abandoned 16 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97295519
- Mark type
- Stylized text
- Filed
- 04 Mar 2022
- Abandoned
- 16 Mar 2023
- Attorney of record
- Christopher Nichols
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, biological and chemical preparations for the prevention and treatment of cancer and infectious diseases
- Class 042 — Scientific and technological services: Research and development in the fields of pharmaceutical, biotechnology, and therapeutics; Research and development of vaccines; scientific study and research in the fields of disease, biochemistry, biology, and/or pharmaceuticals; laboratory research in the field of biology or biochemistry; pharmaceutical drug research and development; pharmaceutical drug discovery and development services; medical research services; medical research services in the field of cancer
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases
Owner
- Immunomic Therapeutics, Inc., Rockville, MD, US
Prosecution history
- 04 Apr 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 03 Apr 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 03 Apr 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Feb 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Feb 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Feb 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Dec 2022 — NON-FINAL ACTION E-MAILED
- 15 Dec 2022 — NON-FINAL ACTION WRITTEN
- 15 Dec 2022 — ASSIGNED TO EXAMINER
- 09 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Mar 2022 — NEW APPLICATION ENTERED